{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:44:59Z","timestamp":1767181499436,"version":"build-2238731810"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China","award":["201402018"],"award-info":[{"award-number":["201402018"]}]},{"name":"Natural Science Foundation of Beijing Municipality (CN)","award":["7164295"],"award-info":[{"award-number":["7164295"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162361","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T13:40:52Z","timestamp":1473255652000},"page":"e0162361","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China"],"prefix":"10.1371","volume":"11","author":[{"given":"Guigao","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiehong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1031","article-title":"Tamoxifen: a most unlikely pioneering medicine","volume":"2","author":"VC Jordan","year":"2003","journal-title":"Nature reviews Drug discovery"},{"issue":"9793","key":"ref2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"C Davies","year":"2011","journal-title":"Lancet"},{"issue":"9869","key":"ref3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"C Davies","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1476-5381.1980.tb10912.x","article-title":"Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships","volume":"71","author":"KE Allen","year":"1980","journal-title":"British journal of pharmacology"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:BREA.0000025406.31193.e8","article-title":"Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen","volume":"85","author":"MD Johnson","year":"2004","journal-title":"Breast cancer research and treatment"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/dna.1991.10.545","article-title":"Debrisoquine\/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population","volume":"10","author":"F Broly","year":"1991","journal-title":"DNA and cell biology"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/clpt.2011.32","article-title":"Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes","volume":"89","author":"L Madlensky","year":"2011","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1349-7006.2008.00780.x","article-title":"Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy","volume":"99","author":"K Kiyotani","year":"2008","journal-title":"Cancer science"},{"issue":"14","key":"ref9","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2217\/pgs.13.160","article-title":"Genetic variations of human CYP2D6 in the Chinese Han population","volume":"14","author":"JC Qian","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/annonc\/mdn155","article-title":"Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment","volume":"19","author":"Y Xu","year":"2008","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology \/ ESMO"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1631\/jzus.B1400282","article-title":"Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia","volume":"16","author":"KF Tang","year":"2015","journal-title":"Journal of Zhejiang University Science B"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10549-011-1777-7","article-title":"Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients","volume":"131","author":"K Kiyotani","year":"2012","journal-title":"Breast cancer research and treatment"},{"key":"ref13","unstructured":"National Health and Family Planning Commision of the People&apos;s Republic of China. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nhfpc.gov.cn\/yzygj\/s3593\/201507\/fca7d0216fed429cac797cdafa2ba466.shtml\" xlink:type=\"simple\">http:\/\/www.nhfpc.gov.cn\/yzygj\/s3593\/201507\/fca7d0216fed429cac797cdafa2ba466.shtml<\/ext-link>."},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FJC.0000000000000254","article-title":"Improvements in CYP2C9 Genotyping Accuracy Are Needed: A Report of the First Proficiency Testing for Warfarin-related CYP2C9 and VKORC1 Genotyping in China","volume":"66","author":"G Lin","year":"2015","journal-title":"Journal of cardiovascular pharmacology"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"e0134174","DOI":"10.1371\/journal.pone.0134174","article-title":"Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach","volume":"10","author":"G Lin","year":"2015","journal-title":"PloS one"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"e0148081","DOI":"10.1371\/journal.pone.0148081","article-title":"Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China","volume":"11","author":"L Yi","year":"2016","journal-title":"PloS one"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2353\/jmoldx.2010.100090","article-title":"Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project","volume":"12","author":"VM Pratt","year":"2010","journal-title":"The Journal of molecular diagnostics: JMD"},{"issue":"5","key":"ref18","first-page":"551","article-title":"Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies","volume":"10","author":"JC Beck","year":"2001","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11033-009-9624-1","article-title":"Maxiprep genomic DNA extractions for molecular epidemiology studies and biorepositories","volume":"37","author":"CA Garcia-Sepulveda","year":"2010","journal-title":"Molecular biology reports"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-006-9428-0","article-title":"The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen","volume":"101","author":"MP Goetz","year":"2007","journal-title":"Breast cancer research and treatment"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/clpt.2011.34","article-title":"Pharmacogenetics: from bench to byte\u2014an update of guidelines","volume":"89","author":"JJ Swen","year":"2011","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.5858\/arpa.2012-0261-CP","article-title":"Genotype and phenotype concordance for pharmacogenetic tests through proficiency survey testing","volume":"137","author":"AH Wu","year":"2013","journal-title":"Archives of pathology & laboratory medicine"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0167740","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:05:44Z","timestamp":1588957544000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162361"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162361","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]}}}